Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,132,711
  • Shares Outstanding, K 80,620
  • Annual Sales, $ 258,610 K
  • Annual Income, $ -850 K
  • 36-Month Beta 0.48
  • Price/Sales 4.38
  • Price/Cash Flow 27.40
  • Price/Book 6.11

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.25 +24.89%
on 05/24/18
14.18 -0.92%
on 06/22/18
+2.59 (+22.60%)
since 05/22/18
3-Month
7.71 +82.23%
on 04/02/18
14.18 -0.92%
on 06/22/18
+5.81 (+70.51%)
since 03/22/18
52-Week
7.08 +98.45%
on 02/06/18
14.18 -0.92%
on 06/22/18
+5.35 (+61.49%)
since 06/22/17

Most Recent Stories

More News
Neogenomics Inc has the Best Relative Performance in the Life Sciences Tools & Services Industry (NEO , CBM , A , PRAH , WAT )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

A : 62.79 (-0.40%)
NEO : 14.05 (+0.93%)
CBM : 47.30 (+0.21%)
Report: Developing Opportunities within ABIOMED, Avid Technology, Unit, Omeros, Strayer Education, and NeoGenomics -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ABIOMED, Inc. (NASDAQ:ABMD),...

ABMD : 427.29 (-2.51%)
STRA : 113.73 (-1.37%)
NEO : 14.05 (+0.93%)
UNT : 24.88 (+4.19%)
AVID : 5.41 (+0.37%)
OMER : 18.67 (+1.19%)
Shares of NEO Up 60.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 4 months, Neogenomics Inc has returned 60.51% as of today's recent price of $13.25.

NEO : 14.05 (+0.93%)
Qiagen Nv is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (QGEN , NEO , CRL , BRKR , PKI )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

NEO : 14.05 (+0.93%)
CRL : 116.21 (+0.41%)
54.6% Return Seen to Date on SmarTrend Neogenomics Inc Call (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 4 months, Neogenomics Inc has returned 54.57% as of today's recent price of $12.76.

NEO : 14.05 (+0.93%)
Neogenomics Inc has the Best Relative Performance in the Life Sciences Tools & Services Industry (NEO , BRKR , MTD , WAT , PRAH )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

BRKR : 30.01 (+1.35%)
NEO : 14.05 (+0.93%)
MTD : 582.31 (+1.04%)
Neogenomics Inc has the Best Relative Performance in the Life Sciences Tools & Services Industry (NEO , BRKR , MTD , WAT , PRAH )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

BRKR : 30.01 (+1.35%)
NEO : 14.05 (+0.93%)
MTD : 582.31 (+1.04%)
Neogenomics Inc has the Best Relative Performance in the Life Sciences Tools & Services Industry (NEO , MTD , TMO , CBM , ILMN )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

TMO : 208.75 (+1.07%)
NEO : 14.05 (+0.93%)
MTD : 582.31 (+1.04%)
Neogenomics Inc Up 45.6% Since SmarTrend Uptrend Call (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 3 months, Neogenomics Inc has returned 45.61% as of today's recent price of $12.02.

NEO : 14.05 (+0.93%)
Shares of Pra Health Scien Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (PRAH , NEO , CRL , WAT , ILMN )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

NEO : 14.05 (+0.93%)
CRL : 116.21 (+0.41%)
PRAH : 95.22 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade NEO with:

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 14.34
1st Resistance Point 14.20
Last Price 14.05
1st Support Level 13.89
2nd Support Level 13.72

See More

52-Week High 14.18
Last Price 14.05
Fibonacci 61.8% 11.47
Fibonacci 50% 10.63
Fibonacci 38.2% 9.79
52-Week Low 7.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar